![]() ![]() ![]() Longer term follow-up to evaluate the maintenance of clinical outcomes is in process. Patient reported outcomes at baseline and follow-up were similar between the two groups. Results showed the fusion rate was significantly higher in the i-FACTOR bone graft group (50 percent) compared to the allograft group (20 percent) at one year (p <0.001). Participants suffered from degenerative spondylolisthesis and underwent decompression and non-instrumented posterolateral fusion surgery, randomized to either i-FACTOR bone graft or fresh frozen allograft bone, both mixed with local bone graft. Michael Kjær Jacobsen, at the Center for Spine Surgery and Research in Southern Denmark, led the double-blind, prospective, randomized study in more than 100 patients (60 years or older). “i-FACTOR shows an increased fusion rate versus allograft.”ĭr. Michael Kjær Jacobsen, principal investigator. “In Scandinavia, surgeons often consider performing non-instrumented fusion when there is instability in elderly patients, but allograft bone has notoriously low fusion rates in this population,” said Dr. The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a statistically significantly higher fusion rate compared to allograft plus local bone. ![]() WESTMINSTER, Colorado, - Cerapedics, a private ortho-biologics company, today announced that results from a clinical trial evaluating i-FACTOR Peptide Enhanced Bone Graft in non-instrumented lumbar fusion surgery has been published in the May 2020, Volume 20, Issue 5 print of The Spine Journal as the lead article. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |